Heart Failure With Reduced Ejection FractionYoga-CaRe HFNCT07817589
Yoga Based Cardiac Rehabilitation in Heart Failure Failure
A study testing Yoga-CaRe HF and Health Education in people with Heart Failure With Reduced Ejection Fraction and Heart Failure NYHA Class II, run by Centre for Chronic Disease Control, India at 16 sites in India.
Trial summary
The clinical study compares the benefits of yoga based rehabilitation programme versus an educational package during recovery of patients with heart failure. Cardiac rehabilitation programmes help patients with cardiac illness to return as quickly as possible to full and productive life and to reduce the chances of… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Heart Failure With Reduced Ejection Fraction, Heart Failure NYHA Class II, Heart Failure NYHA Class III
- What is being tested?
- Yoga-CaRe HF and Health Education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 3,500 participants
- Where
- 16 sitesIndia
- Study dates
- 24 Apr 2023to 30 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Male and female patients above 18years
- Physician diagnosed heart failure patients with reduced ejection fraction based on ESC guidelines
- Patients should be NYHA class II/III
- Willing and able to attend the complete hospital-based CR programme on their own
Who cannot join
- Comorbid disease or behavioral or other limitations that interfere with performing Yoga training or prevent the completion of 1 y of exercise training
- Elective Cardiovascular procedure or hospitalization planned in the coming 3 months
- Currently pregnant or intend to become pregnant in the next year
- Heart failure secondary to significant correctable/reversible cause like primary valvular disease/ correctable congential heat disease
- Performance of exercise training/yoga at regular intervals (more than once per week) at a moderate-to-vigorous intensity at any time in the previous 6 week
- Participation in other clinical trials
Trial locations and contacts
16 sites in 1 country. Contact the study team or a site near you to ask about taking part.
16 sites in 1 country
India16 sites, 12 recruiting
- Recruiting
Sri Jayadeva Institute of Cardiovascular Sciences and Research
Bangalore
Prabhavathi, prabhavathi_in@yahoo.com
- Recruiting
All India Institute of Medical Sciences, Bathinda
Bathinda
Bhupinder Singh, docbhupi@gmail.com
- Suspended
KLES Dr. Prabhakar Kore Charitable Hospital
Belagavi
- Recruiting
Madras Medical College
Chennai, Tamil Nadu, 600003
G Justin Paul, DM Cardiology
- Recruiting
Sri Ramchandra Institute of Higher Education and Research
Chennai, Tamil Nadu, 600116
Nagendra Boopathy, DM Cardiology
- Recruiting
Safdarjung Hospital
Delhi
Anunay Gupta, dranunaygupta@gmail.com
- Recruiting
Sir Ganga Ram Hospital
Delhi
Subhash Chand Manchanda, doctormanchanda@yahoo.com
- Recruiting
SDM College of Medical Sciences & Hospital
Dharwad, Karnataka, 580009
Kiran Aithal, MD General Medicine
- Suspended
All India Institute of Medical Sciences
Jodhpur, Rajasthan, 342005
- Recruiting
Dayanand Medical College and Hospital
Ludhiana, Punjab, 141001
Bishav Mohan, DM Cardiology
- Recruiting
JSS Hospital
Mysore, Karnataka, 570004
Sunil Kumar S, DM Cardiology
- Recruiting
Sri Jayadeva Institute of Cardiovascular Sciences and Research
Mysore
Sadanand K S, sadanand_dm@rediffmail.com
- Active, not recruiting
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, 110029
- Recruiting
All India Institute of Medical Sciences, Rishikesh
Rishikesh, Uttarakand
Bhanu Duggal, bhanu.cardio@aiimsrishikesh.edu.in
- Recruiting
North Eastern Indira Gandhi Regional Institute of Medical Sciences
Shillong, Meghālaya, 793018
Amit Malviya, DM Cardiology
- Suspended
Acharya Vinobha Bhave Rural Hospital
Wardha
About this study
Official title: Effectiveness of Yoga Based Cardiac Rehabilitation (Yoga-CaRe) in Heart Failure: A Randomized Controlled Clinical Trial
The clinical study compares the benefits of yoga based rehabilitation programme versus an educational package during recovery of patients with heart failure. Cardiac rehabilitation programmes help patients with cardiac illness to return as quickly as possible to full and productive life and to reduce the chances of further cardiac illness or death. We want to know whether our package of yoga classes can provide effective cardiac rehabilitation and how that compares with a package of educational classes. Both packages are especially designed by us to improve heart health
- Conditions
- Heart Failure With Reduced Ejection Fraction, Heart Failure NYHA Class II, Heart Failure NYHA Class III
- Being tested
- Yoga-CaRe HF, Health Education
- Keywords
- Heart failure, Yoga, Yoga-CaRe, cardiac rehabilitation, rehabilitation
- Medical subject headings
- Heart Failure
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Yoga-CaRe HFBehavioural
A cardiac rehabilitation programme comprising of health education and yogic practices.
Health EducationBehavioural
Health education on "Healthy Living with Heart Failure"
| Study group | Role | What they receive |
|---|---|---|
| Yoga-CaRe group | Experimental | Yoga based cardiac rehabilitation programme delivered as 20 sessions spread over three months and long term care and follow-up. Receives: Behavioral: Yoga-CaRe HF; Behavioral: Health Education |
| Enhanced standard care | Active comparator | Enhanced standard care comprising of health education delivered in 3 sessions spread over three months. Receives: Behavioral: Health Education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Major Adverse Cardiovascular event
Time to first cardiovascular event
Measured: Median follow-up of 1 year
Heart Failure Specific Quality of life
Change in the Minnesota Living with Heart Failure Questionnaire (MLHFQ) total score from baseline. The MLHFQ consists of 21 items, each scored from 0 (no impact) to 5 (very much impacted), with a total score ranging from 0 to 105. Lower scores indicate better health-related quality of life
Measured: 3 months
Secondary outcomes (8)
Six minute walk test
Six-minute walk distance (6MWD), measured as the total distance in metres walked by the participant during a standardized six-minute walk test. A greater distance indicates better functional exercise capacity.
Measured: 3 months
Generic Quality of life
European Quality of Life (EQ-5D-5L) Questionnaire evaluates five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels. The outcome will be expressed as the EQ-5D-5L utility index score, with higher scores indicating better health-related quality of life.
Measured: 3 months
Self-rated health (EQ-5D-5L)
EQ-VAS score, ranging from 0 to 100, where 0 represents the worst imaginable health state and 100 represents the best imaginable health state. Higher scores indicate better perceived health status.
Measured: 3 months
Tobacco cessation
Smoking cessation will be assessed based on self-reported tobacco use status. Current smokers at baseline who report no tobacco use at follow-up will be classified as having achieved tobacco cessation.
Measured: 3 months
Self-reported Frailty
Frailty assessed by Fried Frailty Phenotype tool
Measured: 3 months
Caregiver's depression - Patient Health Questionnaire-9
PHQ-9 total score, ranging from 0 to 27, with each of the nine items scored from 0 to 3. Higher scores indicate greater severity of depressive symptoms.
Measured: 3 months
Caregiver's Quality of Life - EQ-5D-5L
Quality of life will be assessed using the EQ-5D-5L questionnaire, which evaluates five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels. The outcome will be expressed as the EQ-5D-5L utility index score and visual analogue scale (EQ-VAS), with higher scores indicating better health-related quality of life.
Measured: at 3 months
Costs of care
Cost effectiveness as assessed by a piloted tool
Measured: Median follow-up of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Sep 2026
- Study start24 Apr 2023
- Primary completion30 Nov 2026 (estimated)
- Study completion30 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart Failure With Reduced Ejection FractionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 3,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre for Chronic Disease Control, India
- Sponsor type
- University, hospital or other
- Collaborators
- Indian Council of Medical Research, Central Council for Research in Yoga & Naturopathy, All India Institute of Medical Sciences, All India Institute of Medical Sciences, Bathinda, All India Institute of Medical Sciences, Rishikesh, All India Institute of Medical Sciences, Jodhpur, Dayanand Medical College and Hospital, KLES Prabhakar Kore Hospital Belagavi, JSS Medical College Hospital, SDM College of Medical Sciences & Hospital, North Eastern Indira Gandhi Regional Institute of Health ans Medical Sciences, Sri Ramachandra Institute of Higher Education and Research, Madras Medical College, Acharya Vinoba Bhave Rural Hospital, Sri Jayadeva Institute of Cardiovascular Sciences and Research
- Responsible party
- Principal investigator, Dr. Dorairaj Prabhakaran, Centre for Chronic Disease Control, India
- Investigators
- Dorairaj Prabhakaran, MD DM (Cardiology), Principal investigator, Centre for Chronic Disease Control, New Delhi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07817589
- Sponsor's protocol ID
- CCDC-2023-0001
- Acronym
- Yoga-CaRe HF
- Status last verified
- Oct 2025
- First submitted
- 20 Jul 2026
- Last updated
- 14 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: We are preparing a IPD sharing plan
Study at a glance
From the registry record, last updated by the sponsor on 14 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Yoga Based Cardiac Rehabilitation (Yoga-CaRe) in Heart Failure: A Randomized Controlled Clinical Trial
- ClinicalTrials.gov ID
- NCT07817589
- Acronym / sponsor ID
- Yoga-CaRe HF / CCDC-2023-0001
- Conditions
- Heart Failure With Reduced Ejection Fraction, Heart Failure NYHA Class II, Heart Failure NYHA Class III
- Keywords
- Heart failure, Yoga, Yoga-CaRe, cardiac rehabilitation, rehabilitation
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 3,500 participants (estimated)
- Lead sponsor
- Centre for Chronic Disease Control, IndiaUniversity, hospital or other
- Collaborators
- Indian Council of Medical Research, Central Council for Research in Yoga & Naturopathy, All India Institute of Medical Sciences, All India Institute of Medical Sciences, Bathinda, All India Institute of Medical Sciences, Rishikesh, All India Institute of Medical Sciences, Jodhpur, Dayanand Medical College and Hospital, KLES Prabhakar Kore Hospital Belagavi, JSS Medical College Hospital, SDM College of Medical Sciences & Hospital, North Eastern Indira Gandhi Regional Institute of Health ans Medical Sciences, Sri Ramachandra Institute of Higher Education and Research, Madras Medical College, Acharya Vinoba Bhave Rural Hospital, Sri Jayadeva Institute of Cardiovascular Sciences and Research
- Study start
- 24 Apr 2023 (actual)
- Primary completion
- 30 Nov 2026 (estimated)
- Study completion
- 30 Nov 2026 (estimated)
- First posted
- 14 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The clinical study compares the benefits of yoga based rehabilitation programme versus an educational package during recovery of patients with heart failure. Cardiac rehabilitation programmes help patients with cardiac illness to return as quickly as possible to full and productive life and to reduce the chances of further cardiac illness or death. We want to know whether our package of yoga classes can provide effective cardiac rehabilitation and how that compares with a package of educational classes. Both packages are especially designed by us to improve heart health
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Yoga-CaRe group | Experimental | Behavioral: Yoga-CaRe HF, Behavioral: Health EducationYoga based cardiac rehabilitation programme delivered as 20 sessions spread over three months and long term care and follow-up. |
| Enhanced standard care | Active comparator | Behavioral: Health EducationEnhanced standard care comprising of health education delivered in 3 sessions spread over three months. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Male and female patients above 18years
- Physician diagnosed heart failure patients with reduced ejection fraction based on ESC guidelines
- Patients should be NYHA class II/III
- Willing and able to attend the complete hospital-based CR programme on their own
Key exclusion criteria (6 listed)
- Comorbid disease or behavioral or other limitations that interfere with performing Yoga training or prevent the completion of 1 y of exercise training
- Elective Cardiovascular procedure or hospitalization planned in the coming 3 months
- Currently pregnant or intend to become pregnant in the next year
- Heart failure secondary to significant correctable/reversible cause like primary valvular disease/ correctable congential heat disease
- Performance of exercise training/yoga at regular intervals (more than once per week) at a moderate-to-vigorous intensity at any time in the previous 6 week
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Yoga-CaRe HFA cardiac rehabilitation programme comprising of health education and yogic practices. | Behavioural | Yoga-CaRe group |
| Health EducationHealth education on "Healthy Living with Heart Failure" | Behavioural | Enhanced standard care, Yoga-CaRe group |
Primary outcome
Major Adverse Cardiovascular event
Time frame: Median follow-up of 1 year
Time to first cardiovascular event
Heart Failure Specific Quality of life
Time frame: 3 months
Change in the Minnesota Living with Heart Failure Questionnaire (MLHFQ) total score from baseline. The MLHFQ consists of 21 items, each scored from 0 (no impact) to 5 (very much impacted), with a total score ranging from 0 to 105. Lower scores indicate better health-related quality of life
8 secondary outcomes
Six minute walk test
Time frame: 3 months
Generic Quality of life
Time frame: 3 months
Self-rated health (EQ-5D-5L)
Time frame: 3 months
Tobacco cessation
Time frame: 3 months
Self-reported Frailty
Time frame: 3 months
Caregiver's depression - Patient Health Questionnaire-9
Time frame: 3 months
Caregiver's Quality of Life - EQ-5D-5L
Time frame: at 3 months
Costs of care
Time frame: Median follow-up of 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Sep 2026.
- Individual participant dataSharing planned: Yes. We are preparing a IPD sharing plan
Related trials for Heart Failure With Reduced Ejection Fraction
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Active, not recruiting
Assessment of Combined CCM and ICD Device in HFrEF
Heart Failure, Heart Failure With Reduced Ejection Fraction
Not yet recruiting
RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
Heart Failure and Reduced Ejection Fraction, Heart Failure Chronic
Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction
Heart Failure With Reduced Ejection Fraction (HFrEF)
RecruitingObservational study
Descriptive Study of Circulating Gene or Protein Inflammatory Biomarkers and Bioimpedance Parameters in a Population of Patients Hospitalized for Decompensated Heart Failure With Preserved or Mildly Reduced Cardiac Function
Inflammation Biomarkers, Heart Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Dorairaj Prabhakaran, MD DM (Cardiology) principal investigator
Centre for Chronic Disease Control, New Delhi
16 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Yoga-CaRe HF and Health Education in people with Heart Failure With Reduced Ejection Fraction and Heart Failure NYHA Class II, run by Centre for Chronic Disease Control, India at 16 sites in India.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 16 sites in India. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Dorairaj Prabhakaran, MD DM (+91 11 41618456, dprabhakaran@ccdcindia.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Major Adverse Cardiovascular event (time frame: Median follow-up of 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026.